Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- EVRI +5%, (guides Q1 revs above consensus; alos - seeking to refinance its outstanding $335 mln aggregate principal amount of Senior Secured Notes due 2021)
- ENDP +2.3%, (preannounces Q1 results with revenue in-line with estimates)
M&A news:
- ENRJ +97.4% (pursuing possible strategic transactions involving opportunities both in and outside the oil and gas industry)
- XCO +19.3% (to divest its oil and natural gas properties in South Texas for $300 mln)
- SWFT +15.1% (Swift Transportation and Knight (KNX) announce all stock merger), KNX +2.6%
- XCRA +11.1% (to be acquired by Unic Capital Management for $10.25/share in cash; deal includes go-shop period)
- AKRX +10.8% (confirms discussions with Fresenius SE's (FSNUY) Fresenius Kabi concerning a potential acquisition of Akorn)
Select oil/gas related names showing strength: CHK +2.1%, WLL+2.1%, WFT +2%, MRO +1.8%, PBR +0.9%, CVX +0.9%
Other news:
Other news:
- CYTX +37.2% (FDA has approved an Investigational Device Exemption for a pilot clinical trial to evaluate Cytori Cell Therapy)
- GERN +15.8% (announces that Janssen, Johnson & Johnson (JNJ) subsidiary, has completed the second internal data reviews of IMerge and IMbark)
- RCII +11.7% (announces a new strategic plan focused on its Core US biz)
- SDRL +5.2% (modestly rebounding following last week's 58% decline)
- MNKD +4.5% (entered into a Change of Control Agreement with each of its executive officers)
- BBL +3.8% (in sympathy with BHP shares)
- IGC +3.2% (filed patent applications for IGC-501 in Canada, Israel, and Europe in support of its global cannabis-based combination therapy development initiatives)
- BHP +2.9% (Elliott funds sends letter to BHP's Board that outlines plans to unlock shareholder value)
- BLDP +2.3% (continued strength)
- HTBX +1.2% (Heat Biologics sent Pelican Therapeutics a funding commitment for $910,231 pursuant to Stock Purchase Agreement
Analyst comments:
- CLSN +13% (resumed with a Buy at Rodman & Renshaw; tgt $1.50)
- TSLA +2.3% (upgraded to Overweight from Neutral at Piper Jaffray)
- CY +1.6% (upgraded to Buy from Neutral at SunTrust)
- HRI +1.3% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)
- SKX +1.2% (upgraded to Neutral from Negative at Susquehanna)
- PF +0.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- ULTA +0.7% (upgraded to Buy from Hold at Loop Capital)